Loading

JSM Chemistry

Solvent Free Synthesis, Spectral Studies and Antimicrobial Activities of Substituted (E)-1- Benzylidene-2-(4-Methylphenyl) Hydrazine’s

Research Article | Open Access

  • 1. PG & Research Department of Chemistry, Government Arts College, C-Mutlur,Chidambaram-608 102, India
  • 2. PG & Research Department of Chemistry, Government Arts College, C-Mutlur,Chidambaram-608 102, India
+ Show More - Show Less
Corresponding Authors
Thirunarayanan G, Department of Chemistry, Annamalai University, Annamalainagar, Pin: 608002, India
Abstract

A series of nine number of substituted (E)-1-benzylidene-2-(4-methylphenyl) hydrazines has been synthesized by condensation of 4-methylphenylhydrazine with substituted benzaldehydes using Fly-ash–H2 SO4 catalyst under solvent free condition. This method is experimentally simple, high yielding process with shorter reaction time. The synthesized substituted (E)-1-benzylidene-2-(4-methylphenyl) hydrazines have been assigned by physical constants, UV, IR and NMR spectral data. This UV, IR and NMR spectral data have been utilized for spectral correlation analyses. From the results of spectral correlation analysis assessment of substituent effect have been studied. The antimicrobial activities of all the substituted (E)-1-benzylidene-2-(4-methylphenyl) hydrazines have been studied using disc diffusion method.

Keywords


•    Antimicrobial
•    Hydrazones
•    Solvent free synthesis
•    Spectral correlations

Citation

Rajarajan M, Balaji S, Vijayakumar R, Senbagam R, Manikandan V, et al. (2016) Solvent Free Synthesis, Spectral Studies and Antimicrobial Activities of Substituted (E)-1-Benzylidene-2-(4-Methylphenyl) Hydrazine’s. JSM Chem 4(1): 1021.

INTRODUCTION

Hydrazone containing azomethine –NH?N=CH? protons constitute an important class of compounds for development of new drugs. The general method for the synthesis of hydrazones by the condensation reaction of hydrazine with carbonyl compounds such as aldehydes or ketones in ethanol [1-3]. The azomethine (-CH=N-) carbon important role for biological activity that has been demonstrated various pharmacological activities such as antimicrobial [4], antiplatelet [5], anticancer [6], antiviral [7], antitubercular [8], anticonvulsant [9], analgesic [10], antiinflammatory [11], antitumoral [12], antimalarial [13], analgesic [14], ntiprotozoal [15], antiparasitic [16], cardioprotective [17], antidepressant [18] and anti-HIV [19] activities.

Green chemistry is used for designing chemical products and processes by reducing or eliminating the use of harmful chemicals and/or generating hazardous substances. Various green chemistry methods involving stirring, phase transfer catalyst, ionic liquid and many more techniques like microwave techniques include approaches for the creation of ‘‘benign-bydesign’’ synthetic methods which are now accepted worldwide [20]. This processes designed by green synthesis help in the promotion of resource and efficient utilization of energy. They involve low level of waste and hence the processes are becoming economically and environmentally beneficial.

The catalyst promoted organic synthesis has become one of the hot areas in organic synthesis in the last few decades. At present, a wide range of methods for synthesizing Schiff bases in the presence of catalysts are available viz., ZnCl2 [21], TiCl4 [22], K-10 clay [23], CaO [24], P2 O5 -SiO2 [25] and MnO2 [26]. No report has been found in the literature regarding the synthesis of (E)-1- benzylidene-2-(4-methylphenyl) hydrazines with Fly-ash-H2 SO4 catalyst under grinding method and spectral as well as biological activities. Therefore the authors have taken efforts for the synthesis of (E)-1-benzylidene-2-(4-methylphenyl) hydrazines from 4-methylphenylhydrazine with substituted benzaldehyde using Fly-ash-H2 SO4 catalyst under solvent-free conditions. The intention of the present methodology is a green protocol offering several advantages such as, excellent yield of products, minimizing production of chemical wastes, shorter reaction profile, mild reaction conditions, simple operational procedure, easy preparation of catalyst and its recyclability up to five cycles without any appreciable loss in catalytic activity. The various spectral data of these (E)-1-benzylidene-2-(4-methylphenyl) hydrazines have been utilized for studying the Hammett spectral correlation analyses. The antimicrobial activities of all the substituted (E)-1-benzylidene-2-(4-methylphenyl) hydrazines have been studied using disc diffusion method [27].

 

MATERIALS AND METHODS

All the chemicals and solvents used in this work were purchased from Sigma-Aldrich and E-Merck chemical companies. Melting points of all the (E)-1-benzylidene-2-(4-methylphenyl) hydrazines were determined in open glass capillaries on Mettler FP51 melting point apparatus and are uncorrected. The UV spectra of all substituted (E)-1-benzylidene-2-(4- methylphenyl) hydrazines were recorded with SHIMADZU-1650 SPECTROMETER spectrophotometer λmax (nm) in spectral grade ethanol solvent. The IR spectra were obtained on a SHIMADZU-2010 Fourier transform spectrophotometer. The NMR spectra are recorded in Bruker AV400 NMR spectrometer operating at 400 MHz for 1 H NMR spectra and 100 MHz for 13C spectra in CDCl3 solvent, using TMS as internal standard.

Preparation of Fly-ash–H2SO4 catalyst

In a 50 mL borosil beaker, 3 g of Fly-ash and 3 mL of sulphuric acid have been taken and mixed thoroughly with glass rod at room temperature. This mixture has been heated on a hot air oven at 10 ?C for 1 h, cooled to room temperature, stored in a borosil bottle and tightly capped.

Synthesis of substituted (E)-1-benzylidene-2-(4- methylphenyl) hydrazines

An appropriate equimolar quantity of 4-methylphenylhydrazine (2 mmol) with meta- and para- substituted benzaldehydes (2 mmol) and Fly-ash-H2 SO4 (0.5 g) was thoroughly ground with a pestle in an open mortar at room temperature for 5-10 minutes. Completion of the reaction was monitored by TLC. After the completion of reaction 10 mL of dichloromethane was added and the organic layer separated by filtration, yield solid product on evaporation. The crude product was obtained upon recrystallization from ethanol to give the pure substituted (E)-1-benzylidene-2- (4-methylphenyl) hydrazines and their melting points have been observed. The insoluble catalyst has been recycled by washing with ethyl acetate (10 mL) followed by drying in an air oven at 100°C for 1h and reused for further reactions. The general reaction is as shown in (Scheme 1).

RESULTS AND DISCUSSION

In this work, we have synthesized a series of (E)-1- benzylidene-2-(4-methylphenyl) hydrazine derivatives by condensation of 4-methylphenylhydrazine with substituted benzaldehydes and Fly-ash-H2 SO4 was thoroughly ground with a pestle in an open mortar at room temperature for 5-10 minutes. After the completion of the reaction, the products have been isolated followed by washing the catalyst with ethyl acetate and filtered. To make this catalyst reusable for further reactions, it has been heated to 100°C. In this method is interesting to note that during the condensation there has been no appreciable change in the percentage of the yield of (E)-1-benzylidene-2- (4-methylphenyl) hydrazine, on reusing the same catalyst. It is noteworthy to mention that the green route method requires simple work-up procedure involving simple filtration to isolate the products as they are insoluble in water.

The synthesized (E)-1-benzylidene-2-(4-methylphenyl) hydrazines have been evaluating the assessment of substituent effect on the group frequency such as UV λmax (nm), IR ν(cm1 ) of CH=N, 1 H NMR chemical shift δCH=N(ppm) and 13C NMR chemical shift δC=N (ppm) carbon have been correlated with Hammett substituent constants F and R Swain-Lupton’s parameters using single and multi-linear regression analysis. The physical constants of synthesized (E)-1-benzylidene-2-(4- methylphenyl)hydrazineshave been given in (Table 1). The UV, IR and NMR spectral data of synthesized (E)-1-benzylidene-2-(4- methylphenyl) hydrazines given in (Table 2).

UV Spectral study

The UV absorption λmax (nm) values are correlated [29-33] with Hammett substituent constants and F and R Swain-Lupton’s parameters using single and multi-linear regression analyses [34]. In correlation analysis the Hammett equation employed, as shown in equation (1)

λ = ρ σ + λ0---(1)

Where λ0 is the absorption maximum of the parent member of this series.

The single parameter correlations are given in (Table 3). The correlation analysis of UV absorption maxima λmax (nm) values of all substituted (E)-1-benzylidene-2-(4-methylphenyl) hydrazines with Hammett substituent constants and F and R parameters are found to have failure correlations (r < 0.900) with negative ρ values. This shows that the reverse substituent effects operate in all the systems. The resonance conjugative structure of the substituted (E)-1-benzylidene-2-(4-methylphenyl) hydrazines is shown in (Figure 1). The multi regression analysis of the UV absorption maximum λmaxC=N (nm) values of all the (E)-1- benzylidene-2-(4-methylphenyl) hydrazine compounds with inductive, resonance and F and R Swain-Lupton’s [34] parameters produce satisfactory correlations as shown in equations (2) and (3).

λmax (nm) = 347.61(±5.23) + 4.90(±1.68)σI +4.61(±1.43)σR (2)

(R = 0.925, n = 9, P > 90%)

λmax (nm) = 349.29 (±5.22) + 1.26 (±0.24)F + 4.98 (±1.44)R (3)

(R = 0.919, n = 9, P > 90%)

IR Spectral study

The infrared νCH=N stretching frequencies (cm-1) values of all the synthesized substituted (E)-1-benzylidene-2-(4- methylphenyl) hydrazines have been recorded and presented n (Table 2). These infrared νC=N stretching frequencies (cm1 ) values are correlated [29-33] with Hammett substituent constants and Swain-Lupton’s parameters using single and multi-linear regression analyses [34]. The structure parameter correlation involving group frequencies, the employed Hammett equation is shown in equation (4).

ν = ρ σ + ν0

Where ν0 is the frequency for the parent member series

The results of single parameter statistical analysis [29-33] of all the (E)-1-benzylidene-2-(4-methylphenyl) hydrazine compounds except those with 4-CH3 and 4-OCH3 substituent’s have shown better correlation with Hammett substituent constants σI (r = 0.907) and Swain-Lupton F (r = 0.900) parameters. When the substituent’s that have been given exception are included in regression, they reduce the correlations considerably. The infrared frequency νC=N (cm-1) values of all the (E)-1-benzylidene-2-(4-methylphenyl) hydrazine compounds have shown failure correlations (r < 0.900) with the remaining Hammett constants σ, σ+ , σR and R parameters. This is due to the reason stated earlier, with resonance conjugative structure as shown in (Figure 1). All the correlations gave negative ρ values (except σR and R) parameters. This indicates that reverse substituent effect operates in (E)-1-benzylidene-2-(4- methylphenyl) hydrazines. The multi regression analysis of the infrared νC=N (cm-1) values of all the (E)-1-benzylidene-2-(4- methylphenyl) hydrazines with inductive, resonance and SwainLupton’s [34] parameters produce satisfactory correlations are given in equations (5) and (6).

nC=N(cm-1)=1613.34(±9.80)-55.91(±4.00)σI+24.66(±3.27)
σR (5)
(R = 0.957, n = 9, P > 95%)
nC=N (cm-1)=1611.74(±10.01)-51.64(±3.63)F + 9.61(±2.02)
R (6)
(R = 0.972, n = 9, P > 95%)

NMR Spectral study

1H NMR Spectral study: The 1 H NMR spectra of synthesized (E)-1-benzylidene-2-(4-methylphenyl) hydrazines have been recorded in deuterio chloroform solutions employing tetramethylsilane (TMS) as internal standard. The δCH=N (ppm) chemical shifts values of all the substituted (E)-1-benzylidene-2- (4-methylphenyl) hydrazines were assigned and are presented in (Table 2). These δCH=N (ppm) chemical shifts have been correlated [29-33] with reactivity parameters. Hammett correlation involving group frequencies, the form of the Hammett equation employed is as shown in (7).

δ = ρσ +δ0 (7)

Where δ0 is the chemical shift of the corresponding parent compound.

The results of statistical analysis are presented in (Table 3). From (Table 3), it is evident that the 1 H NMR chemical shift δCH=N (ppm) values of all the (E)-1-benzylidene-2-(4- methylphenyl)hydrazine compounds except those with 4-F and 3-NO2 substituent’s have shown better correlations with Hammett substituent constants namely σ (r = 0.901) and σ+ ( r = 0.900) parameters.

The entire (E)-1-benzylidene-2-(4-methylphenyl) hydrazine compounds except those with 4-F substituent has shown satisfactory correlations with Hammett substituent constants viz., σR (r = 0.900) and R (r = 0.902) parameters. When the substituent’s that have been given exception are included in regression they reduce the correlations considerably. The 1 H NMR chemical shift δCH=N (ppm) values of all the (E)-1- benzylidene-2-(4-methylphenyl) hydrazine compounds have shown poor correlations (r < 0.900) with the remaining σI and F parameters. This is attributed to the weak inductive and field effects of the substituent’s for predicting the reactivity on the δCH=N (ppm) chemical shift through resonance as per the conjugative structure given in (Figure 1). All the correlations with few Hammett substituent constants namely σ, σ+ , σR and F and R parameters have shown positive ρ values. It indicates that the normal substituent’s effect operates with respect to1 H NMR chemical shift δCH=N (ppm) values of all the (E)-1-benzylidene2-(4-methylphenyl) hydrazine compounds.

The multi regression analysis of the 1 H NMR chemical shift δCH=N (ppm) values of all the (E)-1-benzylidene-2-(4- methylphenyl) hydrazine compounds with inductive, resonance and Swain-Lupton’s [34] parameters produce better correlations as shown in equations (8) and (9).

δCH=N(ppm) =7.84(±0.60) - 0.14(±0.01) σI-0.12(±0.01)σR
 (8)
(R= 0.949, n= 9, P> 90%)
δCH=N(ppm) =7.83(±0.56) + 0.17(±0.01) F - 0.06(±0.01) 
R (9)
(R = 0.957, n= 9, P> 95%)

13C NMR Spectral study: The chemical shift δC=N (ppm) values of (E)-1-benzylidene-2-(4-methylphenyl) hydrazines carbon, have been assigned and are presented in (Table 2). The assigned δC=N chemical shift (ppm) values have been made to correlate [29-33] with Hammett substituent constants, field and resonance parameters, with the help of single and multiregression analyses [34] the results of statistical analysis are presented in (Table 3). From (Table 3), it is evident that the 13C NMR chemical shift δC=N (ppm) values of all the (E)-1- benzylidene-2-(4-methylphenyl) hydrazine compounds except that with 4-F substituent has shown better correlations with Hammett substituent constants namely σ (r =0.903) and σ+ (r =0.904) parameters. When the substituent’s that have been given exception included in regression they reduce the correlations considerably.

The 13C NMR chemical shift δC=N (ppm) values of all the (E)-1- benzylidene-2-(4-methylphenyl) hydrazines have shown failure correlations (r < 0.900) with the remaining Hammett substituent constants σI, σR and F and R parameters. The failure correlation is attributed to the conjugated structure shown in (Figure 1). All the correlations have shown negative ρ values with all the Hammett substituent constants and F and R parameters. This indicates the operation of reverse substituent effect with respect to chemical shift δC=N (ppm) values of all the (E)-1-benzyliden -2-(4-methylphenyl) hydrazine compounds. The multi regression analysis of the chemical shift δC=N (ppm) values of all the (E)- 1-benzylidene-2-(4-methylphenyl) hydrazine compounds with inductive, resonance and Swain-Lupton’s [34] parameters produce satisfactory correlations as shown in equations (10) and (11).

δC=N(ppm) = 147.75(±0.93) – 0.25(±0.09)σI – 2.75(±0.12)
σR (10)
(R = 0.946, n = 9, P>90%)
δC=N(ppm) = 147.36(±0.90) + 0.48(±0.07)F – 2.43(±0.18)
R (11)
(R = 0.949, n = 9, P>90%)

Antimicrobial Activities

Antibacterial activity: The antibacterial activities of all the substituted (E)-1-benzylidene-2-(4-methylphenyl) hydrazines have been evaluated against three gram positive pathogenic strains Bacillus substilis, Micrococcus luteus and Staphylococcus aureus and two gram negative strains Escherichia coli and Pseudomonas aeruginosa. The disc diffusion technique was followed using the Kirby–Bauer [27] method, at a concentration of 250 µg/mL with ciprofloxacin used as the standard drugs. The measured antibacterial activities of all substituted (E)-1- benzylidene-2-(4-methylphenyl) hydrazines are presented in (Table 4). The antibacterial activity of all the synthesized (E)- 1-benzylidene-2-(4-methylphenyl) hydrazines are shown in (Figure 2) (Plates 1-10) and the clustered column chart is shown in (Figure 3). There is considerable antibacterial activity was possessed by all substituent’s on the five bacterial species in general.

The (E)-1-benzylidene-2-(4-methylphenyl) hydrazines with 3-Cl, 4-CH3, 4-OCH3 and 3-NO2 substituent’s have shown good antibacterial activity against B. subtilis. The (E)-1-benzylidene-2- (4-methylphenyl) hydrazines with parent (H), 3-Br, 4-Br, 4-F and 4-NO2 substituent’s have shown moderate antibacterial activity against B. subtilis. The 3-Cl, 4-CH3, 4-OCH3 , 3-NO2 and 4-NO2 substituted (E)-1-benzylidene-2-(4-methylphenyl) hydrazine have shown good antibacterial activity against M. luteus. The (E)-1-benzylidene-2-(4-methylphenyl) hydrazines with 3-Cl, 4-F, 4-CH3 , 4-OCH3 , 3-NO2 and 4-NO2 substituent’s have shown good antibacterial activity against S. aureus. The (E)-1-benzylidene2-(4-methylphenyl) hydrazines with parent (H), 3-Br and 4-Br substituent’s have shown moderate antibacterial activity against S. aureus.

The parent (H), 4-Br, 3-Cl, 4-F, 4-CH3, 4-OCH3 , 3-NO2 and 4-NO2 substituted (E)-1-benzylidene-2-(4-methylphenyl) hydrazine compounds have shown good antibacterial activity against E. coli alone. The 3-Br substituted (E)-1-benzylidene2-(4-methylphenyl) hydrazine compound has shown improve the antibacterial activity against E. coli. The 3-Cl, 4-F, 4-CH3 and 4-NO2 substituted (E)-1-benzylidene-2-(4-methylphenyl) hydrazine compounds have shown good antibacterial activity against P. aeruginosa. The (E)-1-benzylidene-2-(4-methylphenyl) hydrazines with parent (H), 3-Br and 3-NO2 substituent’s have shown moderate antibacterial activity against P. aeruginosa. The remaining 4-Br and 4-OCH3 substituted (E)-1-benzylidene2-(4-methylphenyl) hydrazine compounds have shown poor antibacterial activity against P.aeruginosa.

Antifungal activity

Measurement of antifungal sensitivities of all the (E)- 1-benzylidene-2-(4-methylphenyl) hydrazines have been performed using disc diffusion technique [27]. The antifungal activity while for the three strains A. niger, M. species and T. viride the disc diffusion method was adopted. The drugs dilution was 250µg/mL. Miconazole has been taken as the standard drug. The zone of inhibition values of all the (E)-1-benzylidene-2- (4-methylphenyl) hydrazine compound presented in (Table 5). The anti fungal activities of all the (E)-1-benzylidene-2-(4- methylphenyl) hydrazines compounds in the present study are shown in ( Figure 4) (Plates1-6) and the clustered column chart, shown in (Figure 5). All the (E)-1-benzylidene-2-(4-methyl) hydrazine compounds have shown good to moderate activity against all the three fungal species evaluated in general.

The (E)-1-benzylidene-2-(4-methylphenyl)hydrazines having parent (H), 3-Br, 3-NO2 and 4-NO2 substituents have shown good antifungal activity against A. niger.The4-Br, 3-Cl, 4-F, 4-CH3 and 4-OCH3 substituted (E)-1-benzylidene-2-(4-methylphenyl) hydrazine compounds have shown improved activity antifungal activity against A. niger. The (E)-1-benzylidene-2-(4-methylphenyl)hydrazines having parent (H), 3-Br, 4-CH3 , 4-OCH3 , 3-NO2 and 4-NO2 substituent’s have shown good antifungal activity against M. Speciesalone. The (E)-1-benzylidene-2-(4-methylphenyl) hydrazines compounds with parent (H), 3-Br, 4-F, 4-CH3 , 4-OCH3 , 3-NO2 and 4-NO2 substituent’s have shown good antifungal activity against T. viride. The (E)-1-benzylidene-2-(4-methylphenyl) hydrazines having 4-Br, 3-Cl and 4-F substituent’s have shown improve antifungal activity against M. Species. The 4-Br and 3-Cl substituted (E)-1-benzylidene-2-(4-methylphenyl) hydrazines compounds have shown improved antifungal activity against T. viride alone.

Table 1: Physical constants of substituted (E)-1-benzylidene-2-(4-methylphenyl) hydrazines.

Entry X m.p (°C) Mol.
formula
Mol.
weight
Yield (%)
1 H 93-94
93-94 [28]
C14H14N2 210 94
2 3-Br 134-155 C14H13N2 Br 289 92
3 4-Br 151-152 C14H13N2 Br 289 90
4 3-Cl 139-140 C14H13N2 Cl 244 95
5 4-F 119-120 C14H13N2 F 228 91
6 4-CH3 129-130 C15H16N2 224 90
7 4-OCH3 162-163 C15H16N2 O 240 93
8 3-NO2 137-138 C14H13N3 O2 255 95
9 4-NO2 127-128 C14H13N3 O2 286 96

Table 2: UV, IR and NMR Spectral data of substituted (E)-1-benzylidene-2-(4-methylphenyl) hydrazines.

Entry X UV λmax (nm) IR(ν, cm-1) C=N 1H NMR (δ, ppm) 
CH=N
13C NMR (δ, ppm)
C=N
1 H 345.5 1620.21 7.905 148.72
2 3-Br 357.5 1573.91 7.852 147.93
3 4-Br 358.5 1573.91 7.878 146.10
4 3-Cl 354.5 1570.06 7.953 143.44
5 4-F 339.5 1570.06 8.111 144.53
6 4-CH3 344.0 1604.76 7.871 145.60
7 4-OCH3 345.8 1610.56 7.833 148.62
8 3-NO2 351.5 1583.56 7.868 147.96
9 4-NO2 343.0 1593.20 7.988 146.88

Table 3: The results of statistical analysis of UV λmax (nm), IR ν (cm-1) of CH=N, 1 H NMR chemical shift δCH=N (ppm) and 13C NMR chemical shift δC=N (ppm) data of substituted (E)-1-benzylidene-2-(4-methylphenyl) hydrazines with Hammett constants σ, σ+, σI & σR and F and R parameters.

Frequency Constant r I ρ s n Correlated derivatives
λmax nm σ 0.862 350.67 -3.01 4.81 9 H, 3-Br, 4-Br, 3-Cl, 4-F, 4-CH3 , 4-OCH3 , 3-NO2 , 4-NO2
  σ+ 0.862 349.97 -0.65 4.93 9 H, 3-Br, 4-Br, 3-Cl, 4-F, 4-CH3 , 4-OCH3 , 3-NO2 , 4-NO2
  σI 0.816 351.46 -3.75 4.87 9 H, 3-Br, 4-Br, 3-Cl, 4-F, 4-CH3 , 4-OCH3 , 3-NO2 , 4-NO2
  σR 0.827 349.02 -5.76 4.75 9 H, 3-Br, 4-Br, 3-Cl, 4-F, 4-CH3 , 4-OCH3 , 3-NO2 , 4-NO2
  F 0.820 351.76 -4.26 4.83 9 H, 3-Br, 4-Br, 3-Cl, 4-F, 4-CH3 , 4-OCH3 , 3-NO2 , 4-NO2
  R 0.826 348.98 -4.63 4.76 9 H, 3-Br, 4-Br, 3-Cl, 4-F, 4-CH3 , 4-OCH3 , 3-NO2 , 4-NO2
ν(cm-1) CH=N σ 0.846 1594.58 -24.04 17.98 9 H, 3-Br, 4-Br, 3-Cl, 4-F, 4-CH3 , 4-OCH3 , 3-NO2 , 4-NO2
  σ+ 0.907 1608.95 -52.92 14.407 7 H, 3-Br, 4-Br, 3-Cl, 4-CH3 , 4-OCH3 , 4-NO2
  σI 0.717 1590.96 15.49 20.05 9 H, 3-Br, 4-Br, 3-Cl, 4-F, 4-CH3 , 4-OCH3 , 3-NO2 , 4-NO2
  σR 0.900 1610.06 -52.00 13.96 7 H, 3-Br, 4-Br, 3-Cl, 4-CH3 , 4-OCH3 , 4-NO2
  F 0.750 1591.12 11.65 20.11 9 H, 3-Br, 4-Br, 3-Cl, 4-F, 4-CH3 , 4-OCH3 , 3-NO2 , 4-NO2
  R 0.901 7.90 0.03 0.09 7 H, 3-Br, 4-Br, 3-Cl, 4-CH3 , 4-OCH3 , 4-NO2
δ(ppm) CH= N σ 0.900 7.91 0.02 0.09 7 H, 3-Br, 4-Br, 3-Cl, 4-CH3 , 4-OCH3 , 4-NO2
  σ+ 0.739 7.86 0.13 0.08 9 H, 3-Br, 4-Br, 3-Cl, 4-F, 4-CH3 , 4-OCH3 , 3-NO2 , 4-NO2
  σI 0.900 7.90 -0.10 0.09 8 H, 3-Br, 4-Br, 3-Cl, 4-CH3 , 4-OCH3 , 3-NO2 , 4-NO2
  σR 0.875 7.84 0.17 0.07 9 H, 3-Br, 4-Br, 3-Cl, 4-F, 4-CH3 , 4-OCH3 , 3-NO2 , 4-NO2
  F 0.902 7.90 -0.07 0.09 8 H, 3-Br, 4-Br, 3-Cl, 4-CH3 , 4-OCH3 , 3-NO2 , 4-NO2
  R 0.903 148.23 -1.31 1.32 8 H, 3-Br, 4-Br, 3-Cl, 4-CH3 , 4-OCH3 , 3-NO2 , 4-NO2
δ(ppm) C=N σ 0.904 148.23 -1.22 1.26 8 H, 3-Br, 4-Br, 3-Cl, 4-CH3 , 4-OCH3 , 3-NO2 , 4-NO2
  σ+ 0.711 148.24 -0.59 1.41 9 H, 3-Br, 4-Br, 3-Cl, 4-F, 4-CH3 , 4-OCH3 , 3-NO2 , 4-NO2
  σI 0.711 148.24 -0.59 1.41 9 H, 3-Br, 4-Br, 3-Cl, 4-F, 4-CH3 , 4-OCH3 , 3-NO2 , 4-NO2
  σR 0.820 147.65 -2.79 1.26 9 H, 3-Br, 4-Br, 3-Cl, 4-F, 4-CH3 , 4-OCH3 , 3-NO2 , 4-NO2
  F 0.711 147.78 -0.57 1.41 9 H, 3-Br, 4-Br, 3-Cl, 4-F, 4-CH3 , 4-OCH3 , 3-NO2 , 4-NO2
  R 0.810 147.55 -2.45 3.60 9 H, 3-Br, 4-Br, 3-Cl, 4-F, 4-CH3 , 4-OCH3 , 3-NO2 , 4-NO2
Abbreviations: r: Correlation coefficient; I: Intercept; ρ: Slope; s: standard deviation; n: Number of correlated derivatives

Table 4: Antibacterial activity of substituted (E)-1-benzylidene-2-(4-methylphenyl) hydrazines.

S.No X Zone of inhibition (mm)
Gram positive Bacteria Gram negative Bacteria
B. subtilis M. luteus S. aureus E. coli P. aeruginosa
1 H 7 0 8 10 6
2 3-Br 6 0 6 8 6
3 4-Br 6 8 9 16 0
4 3-Cl 12 11 10 15 14
5 4-F 9 9 10 12 10
6 4-CH3 13 10 12 13 10
7 4-OCH3 16 13 10 10 0
8 3-NO2 14 12 10 16 9
9 4-NO2 8 16 12 15 10
Standard Ciprofloxacin 16 15 16 16 15
Control DMSO 0 0 0 0 0

Table 5: Antifungal activity of substituted (E)-1-benzylidene-2-(4-methylphenyl) hydrazines.

S. No. X Zone of inhibition(mm)
A. niger M. species T. viride
1 H 10 13 10
2 3-Br 10 12 10
3 4-Br 6 6 7
4 3-Cl 6 6 6
5 4-F 6 7 13
6 4-CH3 9 12 10
7 4-OCH3 8 11 11
8 3-NO2 13 14 13
9 4-NO2 14 16 12
Standard Ciprofloxacin 20 24 22
Control DMSO 0 0 0

 

CONCLUSION

In the present research work, we have synthesized a series of substituted (E)-1-benzylidene-2-(4-methylphenyl) hydrazine compounds from substituted benzaldehydes with 4-methylphenylhydrazine using Fly-ash-H2 SO4 catalyst under solvent free condition. This method involves simple work-up procedure, shorter reaction time (5-10 minutes), eco-friendly, non-hazarders with excellent yield more than 90%. The synthesized substituted (E)-1-benzylidene-2-(4-methylphenyl) hydrazine compounds conformed by their physical constant, UV, IR and NMR spectral data. The UV λmax (nm), IR ν (cm-1) of CH=N, 1 H NMR chemical shift δ CH=N (ppm) and 13C NMR chemical shift δC=N (ppm) data have been correlated with Hammett substituent constants and Swain-Lupton’s constants using single and multiregression analysis. From the results some of the single parameter correlations gave satisfactory correlation coefficients. The multiregression analysis gave satisfactory correlation coefficients in all spectral data. The antimicrobial activity of all the substituted (E)-1-benzylidene-2-(4-methylphenyl) hydrazine compounds have shown good to moderate and poor activity against all the microorganism

ACKNOWLEDGEMENTS

The authors thank to DST NMR Facility Unit, Department of Chemistry, Annamalai University, Annamalainagar-608002 for recording NMR spectra of all the (E)-1-benzylidene-2-(4- methylphenyl) hydrazine compounds.

REFERENCES

1. Berdinskii S. The chemistry of hydrazones. Chem Hetero Comp.1979; 15: 238-244.

2. Smith PAS. Benjamin Cummings. Reading Mass. 1983.

3. Polshettiwar V, Varma RS. Polystyrene Sulfonic Acid Catalyzed Greener Synthesis of Hydrazones in Aqueous Medium Using Microwaves. Tetrahedron Lett. 2007; 48: 5649-5652.

4. Rollas S, Gulerman N, Erdeniz H. Synthesis and antimicrobial activity of some new hydrazones of 4-fluorobenzoic acid hydrazide and 3-acetyl-2,5-disubstituted-1,3,4-oxadiazolines. Farmaco. 2002; 57: 171-174.

5. Silva GA, Costa LM, Brito FC, Miranda AL, Barreiro EJ, Fraga CA. New class of potent antinociceptive and antiplatelet 10H-phenothiazine-1- acylhydrazone derivatives. Bioorg Med Chem. 2004; 12: 3149-3158.

6. Savini L, Chiasserini L, Travagli V, Pellerano C, Novellino E, Cosentino S, et al. New alpha-(N)-hetero cyclic hydrazones: evaluation of anticancer, anti-HIV and antimicrobial activity. Eur J Med Chem. 2004; 39: 113-122.

7. Abdel-Aal MT, El-Sayed WA, El-Ashry el-SH. Synthesis and antiviral evaluation of some sugar aryl glycinoyl hydrazones and their oxadiazoline derivatives. Arch Pharm (Weinheim). 2006; 339: 656- 663.

8. Imramovský A, Polanc S, Vinsová J, Kocevar M, Jampílek J, Recková Z, et al. A new modification of anti-tubercular active molecules. Bioorg Med Chem. 2007; 15: 2551-2559.

9. Dimmock JR, Vasishtha SC, Stables JP. Anticonvulsant properties of various acetylhydrazones, oxamoylhydrazones and semicarbazones derived from aromatic and unsaturated carbonyl compounds. Eur J Med Chem. 2000; 35: 241-248.

10. Lima PC, Lima LM, da Silva KC, Léda PH, de Miranda AL, Fraga CA, et al. Synthesis and analgesic activity of novel N-acylarylhydrazones and isosters, derived from natural safrole. Eur J Med Chem. 2000; 35: 187- 203.

11. Salgin-Gök?en U, Gökhan-Kelekçi N, Gökta? O, Köysal Y, Kiliç E, I?ik S, et al. 1-Acylthiosemicarbazides, 1,2,4-triazole-5(4H)- thiones, 1,3,4-thiadiazoles and hydrazones containing 5-methyl2-benzoxazolinones: synthesis, analgesic-anti-inflammatory and antimicrobial activities. Bioorg Med Chem. 2007; 15: 5738-5751.

12. El-Hawash SA, Abdel Wahab AE, El-Demellawy MA. Cyanoacetic acid hydrazones of 3-(and 4-) acetylpyridine and some derived ring systems as potential antitumor and anti-HCV agents. Arch Pharm (Weinheim). 2006; 339: 14-23.

13. Belkheiri N, Bouguerne B, Bedos-Belval F, Duran H, Bernis C, Salvayre R, et al. Synthesis and antioxidant activity evaluation of a syringic hydrazones family. Eur J Med Chem. 2010; 45: 3019-3026.

14. Duarte CD, Barreiro EJ, Fraga CA. Privileged structures: a useful concept for the rational design of new lead drug candidates. Mini Rev Med Chem. 2007; 7: 1108-1119.

15. Caputto ME, Fabian LE, Benítez D, Merlino A, Ríos N, Cerecetto H, et al. Thiosemicarbazones derived from 1-indanones as new antiTrypanosoma cruzi agents. Bioorg Med Chem. 2011; 19: 6818-6826.

16. Aslam MA, Mahmood SU, Shahid M, Saeed A, Iqbal J. Synthesis, biological assay in vitro and molecular docking studies of new Schiff base derivatives as potential urease inhibitors. Eur J Med Chem. 2011; 46: 5473-5479.

17. el-Sabbagh OI, Shabaan MA, Kadry HH, Al-Din ES. New octahydroquinazoline derivatives: synthesis and hypotensive activity. Eur J Med Chem. 2010; 45: 5390-5396.

18. Catto M, Aliano R, Carotti A, Cellamare S, Palluotto F, Purgatorio R, et al. Design, synthesis and biological evaluation of indane-2-arylhydrazinylmethylene-1, 3-diones and indol-2- aryldiazenylmethylene-3-ones as beta-amyloid aggregation inhibitors. Eur J Med Chem. 2010; 45: 1359-1366.

19. Kajal A, Bala S, Sharma N, Kamboj S, Saini V. Therapeutic potential of hydrazones as anti-inflammatory agents. Int J Med Chem. 2014; 2014: 761030.

20. V Koteswara Raoa, S Subba Reddya, B Satheesh Krishnaa, K Reddi Mohan Naidua, C Naga Rajua, SK Ghoshb, et al. Synthesis of Schiff’s bases in aqueous medium: a green alternative approach with effective mass yield and high reaction rates. Green Chem Lett Rev. 2010; 3: 217- 223.

21. Billman JH, Tai KM. Reduction of Schiff bases II: benzhydrylamines and structurally related compounds. J Org Chem. 1958; 23: 535-539.

22. White WA, Weingarten H. A versatile new enamine synthesis. J Org Chem. 1967; 32: 213–214.

23. Varma RS, Dahiya R, Kumar S. Clay catalyzed synthesis of imines and enamines under solvent-free conditions using microwave irradiation. Tetrahedron Lett.1997; 38: 2039–2042.

24. Gopalakrishnan M, Sureshkumar P, Kanagarajan V, Thanusu J. New environmentally-friendly solvent-free synthesis of imines using calcium oxide under microwave irradiation. Res Chem Intermed. 2007; 33: 541-548.

25. Hasaninejad A, Zare A, Sharghi H, Shekouhy M. P2O5/SiO2 an efficient, green and heterogeneous catalytic system for the solvent-free synthesis of N-sulfonyl imines. Arkicov. 2008; 1: 64-74.

26. Blackburn L, Taylor RJ. In situ oxidation-imine formation-reduction routes from alcohols to amines. Org Lett. 2001; 3: 1637-1639.

27. Bauer AW, Kirby WMM, Sherris JC, Truck M. Antibiotic susceptibility testing by a standardized single disk method. Am J Clinical Pathology. 1966; 45: 493-498.

28. Rong Hu J, Jia Zhang W, Gui Zheng D. A one-pot synthesis of bisarylhydrazones by Cu (I)-catalyzed aerobic oxidation. Tetrahedron. 2013; 69: 9865-9869.

29. R Senbagama, M Rajarajana, R Vijayakumara, V Manikandana, S Balajia, G Vanangamudia, et al. Synthesis, Assessment of substituent effect and Antimicrobial activities of some substituted (E)-N-benzylidene-4H1,2,4-triazol-4-amines. World Scientific News. 2015; 2: 211-226.

30. R Senbagam, R Vijayakumar, V Manikandan, S Balaji, G Vanangamudi, G Thirunarayanan, et al. Synthesis, spectral studies and antimicrobial activities of some substituted (E)-1-benzylidene-2- (4-bromophenyl) hydrazines. World Scientific News. 2015; 9: 155-171.

31. R Senbagam, M Rajarajan, R Vijayakumar, V Manikandan, S Balaji, G Vanangamudi, et al. Synthesis, spectral correlations and antimicrobial activities of 2-pyrimidine Schiff’s bases. Int Lett Chem Phy Astro. 2015; 53: 154-164.

32. R Senbagama, R Vijayakumara, M Rajarajana, S Balajia, V Manikandana, G Vanangamudia, et al. Synthesis, assessment of substituent effect and antimicrobial activities of (4E)-4-(benzylideneamino)-1,2-dihydro2,3-dimethyl-1-phenylpyrazol-5-one compounds. Karbala Int J Modern Sci. 2016; 2: 56-62.

33. Rajarajan M. Synthesis, spectral correlations and antimicrobial activities of substituted 4-((E)-2-benzylidenehydrazinyl) benzonitriles. Indian J Chem. 2016; 55: 197-206.

34. Swain CG, Lupton EC. Field and resonance components in substituent effects. J Am Chem Soc.1968; 90: 4328-4337

Received : 14 Apr 2016
Accepted : 04 May 2016
Published : 07 May 2016
Journals
Annals of Otolaryngology and Rhinology
ISSN : 2379-948X
Launched : 2014
JSM Schizophrenia
Launched : 2016
Journal of Nausea
Launched : 2020
JSM Internal Medicine
Launched : 2016
JSM Hepatitis
Launched : 2016
JSM Oro Facial Surgeries
ISSN : 2578-3211
Launched : 2016
Journal of Human Nutrition and Food Science
ISSN : 2333-6706
Launched : 2013
JSM Regenerative Medicine and Bioengineering
ISSN : 2379-0490
Launched : 2013
JSM Spine
ISSN : 2578-3181
Launched : 2016
Archives of Palliative Care
ISSN : 2573-1165
Launched : 2016
JSM Nutritional Disorders
ISSN : 2578-3203
Launched : 2017
Annals of Neurodegenerative Disorders
ISSN : 2476-2032
Launched : 2016
Journal of Fever
ISSN : 2641-7782
Launched : 2017
JSM Bone Marrow Research
ISSN : 2578-3351
Launched : 2016
JSM Mathematics and Statistics
ISSN : 2578-3173
Launched : 2014
Journal of Autoimmunity and Research
ISSN : 2573-1173
Launched : 2014
JSM Arthritis
ISSN : 2475-9155
Launched : 2016
JSM Head and Neck Cancer-Cases and Reviews
ISSN : 2573-1610
Launched : 2016
JSM General Surgery Cases and Images
ISSN : 2573-1564
Launched : 2016
JSM Anatomy and Physiology
ISSN : 2573-1262
Launched : 2016
JSM Dental Surgery
ISSN : 2573-1548
Launched : 2016
Annals of Emergency Surgery
ISSN : 2573-1017
Launched : 2016
Annals of Mens Health and Wellness
ISSN : 2641-7707
Launched : 2017
Journal of Preventive Medicine and Health Care
ISSN : 2576-0084
Launched : 2018
Journal of Chronic Diseases and Management
ISSN : 2573-1300
Launched : 2016
Annals of Vaccines and Immunization
ISSN : 2378-9379
Launched : 2014
JSM Heart Surgery Cases and Images
ISSN : 2578-3157
Launched : 2016
Annals of Reproductive Medicine and Treatment
ISSN : 2573-1092
Launched : 2016
JSM Brain Science
ISSN : 2573-1289
Launched : 2016
JSM Biomarkers
ISSN : 2578-3815
Launched : 2014
JSM Biology
ISSN : 2475-9392
Launched : 2016
Archives of Stem Cell and Research
ISSN : 2578-3580
Launched : 2014
Annals of Clinical and Medical Microbiology
ISSN : 2578-3629
Launched : 2014
JSM Pediatric Surgery
ISSN : 2578-3149
Launched : 2017
Journal of Memory Disorder and Rehabilitation
ISSN : 2578-319X
Launched : 2016
JSM Tropical Medicine and Research
ISSN : 2578-3165
Launched : 2016
JSM Head and Face Medicine
ISSN : 2578-3793
Launched : 2016
JSM Cardiothoracic Surgery
ISSN : 2573-1297
Launched : 2016
JSM Bone and Joint Diseases
ISSN : 2578-3351
Launched : 2017
JSM Bioavailability and Bioequivalence
ISSN : 2641-7812
Launched : 2017
JSM Atherosclerosis
ISSN : 2573-1270
Launched : 2016
Journal of Genitourinary Disorders
ISSN : 2641-7790
Launched : 2017
Journal of Fractures and Sprains
ISSN : 2578-3831
Launched : 2016
Journal of Autism and Epilepsy
ISSN : 2641-7774
Launched : 2016
Annals of Marine Biology and Research
ISSN : 2573-105X
Launched : 2014
JSM Health Education & Primary Health Care
ISSN : 2578-3777
Launched : 2016
JSM Communication Disorders
ISSN : 2578-3807
Launched : 2016
Annals of Musculoskeletal Disorders
ISSN : 2578-3599
Launched : 2016
Annals of Virology and Research
ISSN : 2573-1122
Launched : 2014
JSM Renal Medicine
ISSN : 2573-1637
Launched : 2016
Journal of Muscle Health
ISSN : 2578-3823
Launched : 2016
JSM Genetics and Genomics
ISSN : 2334-1823
Launched : 2013
JSM Anxiety and Depression
ISSN : 2475-9139
Launched : 2016
Clinical Journal of Heart Diseases
ISSN : 2641-7766
Launched : 2016
Annals of Medicinal Chemistry and Research
ISSN : 2378-9336
Launched : 2014
JSM Pain and Management
ISSN : 2578-3378
Launched : 2016
JSM Women's Health
ISSN : 2578-3696
Launched : 2016
Clinical Research in HIV or AIDS
ISSN : 2374-0094
Launched : 2013
Journal of Endocrinology, Diabetes and Obesity
ISSN : 2333-6692
Launched : 2013
Journal of Substance Abuse and Alcoholism
ISSN : 2373-9363
Launched : 2013
JSM Neurosurgery and Spine
ISSN : 2373-9479
Launched : 2013
Journal of Liver and Clinical Research
ISSN : 2379-0830
Launched : 2014
Journal of Drug Design and Research
ISSN : 2379-089X
Launched : 2014
JSM Clinical Oncology and Research
ISSN : 2373-938X
Launched : 2013
JSM Bioinformatics, Genomics and Proteomics
ISSN : 2576-1102
Launched : 2014
Journal of Trauma and Care
ISSN : 2573-1246
Launched : 2014
JSM Surgical Oncology and Research
ISSN : 2578-3688
Launched : 2016
Annals of Food Processing and Preservation
ISSN : 2573-1033
Launched : 2016
Journal of Radiology and Radiation Therapy
ISSN : 2333-7095
Launched : 2013
JSM Physical Medicine and Rehabilitation
ISSN : 2578-3572
Launched : 2016
Annals of Clinical Pathology
ISSN : 2373-9282
Launched : 2013
Annals of Cardiovascular Diseases
ISSN : 2641-7731
Launched : 2016
Journal of Behavior
ISSN : 2576-0076
Launched : 2016
Annals of Clinical and Experimental Metabolism
ISSN : 2572-2492
Launched : 2016
Clinical Research in Infectious Diseases
ISSN : 2379-0636
Launched : 2013
JSM Microbiology
ISSN : 2333-6455
Launched : 2013
Journal of Urology and Research
ISSN : 2379-951X
Launched : 2014
Journal of Family Medicine and Community Health
ISSN : 2379-0547
Launched : 2013
Annals of Pregnancy and Care
ISSN : 2578-336X
Launched : 2017
JSM Cell and Developmental Biology
ISSN : 2379-061X
Launched : 2013
Annals of Aquaculture and Research
ISSN : 2379-0881
Launched : 2014
Clinical Research in Pulmonology
ISSN : 2333-6625
Launched : 2013
Journal of Immunology and Clinical Research
ISSN : 2333-6714
Launched : 2013
Annals of Forensic Research and Analysis
ISSN : 2378-9476
Launched : 2014
JSM Biochemistry and Molecular Biology
ISSN : 2333-7109
Launched : 2013
Annals of Breast Cancer Research
ISSN : 2641-7685
Launched : 2016
Annals of Gerontology and Geriatric Research
ISSN : 2378-9409
Launched : 2014
Journal of Sleep Medicine and Disorders
ISSN : 2379-0822
Launched : 2014
JSM Burns and Trauma
ISSN : 2475-9406
Launched : 2016
Chemical Engineering and Process Techniques
ISSN : 2333-6633
Launched : 2013
Annals of Clinical Cytology and Pathology
ISSN : 2475-9430
Launched : 2014
JSM Allergy and Asthma
ISSN : 2573-1254
Launched : 2016
Journal of Neurological Disorders and Stroke
ISSN : 2334-2307
Launched : 2013
Annals of Sports Medicine and Research
ISSN : 2379-0571
Launched : 2014
JSM Sexual Medicine
ISSN : 2578-3718
Launched : 2016
Annals of Vascular Medicine and Research
ISSN : 2378-9344
Launched : 2014
JSM Biotechnology and Biomedical Engineering
ISSN : 2333-7117
Launched : 2013
Journal of Hematology and Transfusion
ISSN : 2333-6684
Launched : 2013
JSM Environmental Science and Ecology
ISSN : 2333-7141
Launched : 2013
Journal of Cardiology and Clinical Research
ISSN : 2333-6676
Launched : 2013
JSM Nanotechnology and Nanomedicine
ISSN : 2334-1815
Launched : 2013
Journal of Ear, Nose and Throat Disorders
ISSN : 2475-9473
Launched : 2016
JSM Ophthalmology
ISSN : 2333-6447
Launched : 2013
Journal of Pharmacology and Clinical Toxicology
ISSN : 2333-7079
Launched : 2013
Annals of Psychiatry and Mental Health
ISSN : 2374-0124
Launched : 2013
Medical Journal of Obstetrics and Gynecology
ISSN : 2333-6439
Launched : 2013
Annals of Pediatrics and Child Health
ISSN : 2373-9312
Launched : 2013
JSM Clinical Pharmaceutics
ISSN : 2379-9498
Launched : 2014
JSM Foot and Ankle
ISSN : 2475-9112
Launched : 2016
JSM Alzheimer's Disease and Related Dementia
ISSN : 2378-9565
Launched : 2014
Journal of Addiction Medicine and Therapy
ISSN : 2333-665X
Launched : 2013
Journal of Veterinary Medicine and Research
ISSN : 2378-931X
Launched : 2013
Annals of Public Health and Research
ISSN : 2378-9328
Launched : 2014
Annals of Orthopedics and Rheumatology
ISSN : 2373-9290
Launched : 2013
Journal of Clinical Nephrology and Research
ISSN : 2379-0652
Launched : 2014
Annals of Community Medicine and Practice
ISSN : 2475-9465
Launched : 2014
Annals of Biometrics and Biostatistics
ISSN : 2374-0116
Launched : 2013
JSM Clinical Case Reports
ISSN : 2373-9819
Launched : 2013
Journal of Cancer Biology and Research
ISSN : 2373-9436
Launched : 2013
Journal of Surgery and Transplantation Science
ISSN : 2379-0911
Launched : 2013
Journal of Dermatology and Clinical Research
ISSN : 2373-9371
Launched : 2013
JSM Gastroenterology and Hepatology
ISSN : 2373-9487
Launched : 2013
Annals of Nursing and Practice
ISSN : 2379-9501
Launched : 2014
JSM Dentistry
ISSN : 2333-7133
Launched : 2013
Author Information X